335 results on '"Malmberg K"'
Search Results
2. Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
3. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
4. Genetic ablation of adhesion ligands effectively averts rejection of allogeneic immune cells
5. Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
6. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
7. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
8. VITAMIN D DEFICIENCY AND COMPLICATIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: PH-P412
9. INTERIM REPORT OF A CLINICAL STUDY WITH HAPLOIDENTICAL NK-CELLS AGAINST HIGH RISK MDS AND AML: PH-P073
10. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study
11. Mapping the diversity of human KIR repertoires and their adaptation to infection: W49.006
12. Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial
13. High sense of coherence in adolescence is a protective factor in the longitudinal development of ADHD symptoms
14. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes
15. Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China
16. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial
17. A RANDOMIZED TRIAL ON THE IMPACT OF STRICT GLYCAEMIC CONTROL ON MYOCARDIAL DIASTOLIC FUNCTION AND PERFUSION RESERVE A REPORT FROM THE DADD-STUDY
18. Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
19. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart
20. Insulin infusions in acute cardiac illness, DIGAMI and beyond: 1832
21. Insulin-like growth factor binding protein-1 predicts cardiovascular events in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial: A105
22. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
23. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes
24. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction☆
25. Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population-based controls
26. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients
27. User Engagement for Large Scale Pilots in the Internet of Things
28. Homeostasis model assessment of insulin resistance and survival in patients with diabetes and acute coronary syndrome
29. Adiponectin, free fatty acids, and cardiovascular outcomes in patients with type 2 diabetes and acute coronary syndrome
30. Erratum to: Feature frequency effects in recognition memory
31. Elevated levels of adipokines predict outcome after acute myocardial infarction : A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
32. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart
33. Elevated levels of adipokines predict outcome after acute myocardial infarction : long-term follow-up of the GAMI cohort
34. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart
35. Den prognostiska betydelsen av nyupptäckt glukosstörning hos patienter med akut hjärtinfarkt – en långtidsuppföljning av GAMI-studien.
36. Testosterone in patients with acute myocardial infarction and glucose abnormalities and in matched controls - a report from the GAMI study.
37. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells
38. Testosterone in patients with acute myocardial infarction and glucose abnormalities and in matched controls : a report from the GAMI study
39. Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
40. Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
41. Mannose-binding lectin genotype and phenotype and their impact on cardiovascular prognosis in patients with type 2 diabetes and myocardial infarction; a report from the DIGAMI 2 trial
42. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text
43. Terapia farmacologica e procedure di rivascolarizzazione: estremamente efficaci nei pazienti diabetici con coronaropatia
44. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
45. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
46. Glucose lowering treatment is prognostically important in patients with coronary artery disease and newly detected diabetes mellitus. A report from a Euro Heart Survey
47. Achieving glucometabolic control in diabetic patients - does therapeutic modality matter? A report from the Euro Heart Survey on diabetes and the heart
48. Glucose lowering therapy in post myocardial infarction patients with diabetes – is insulin safe? A report from the Euro Heart Survey on Diabetes and the Heart
49. Рекомендации по лечению сахарного диабета, преддиабета и сердечно-сосудистых заболеваний Рабочая группа по диабету и сердечно-сосудистым заболеваниям Европейского общества кардиологов и Европейской ассоциации по изучению диабета
50. Newly detected diabetes and coronary artery disease - is lifestyle intervention appropriate? A report from the Euro Heart Survey on diabetes and the heart
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.